Morning Briefing
Summaries of health policy coverage from major news organizations
White House Vaccine Summit Proclaims Success Of Operation Warp Speed
U.S. President Donald Trump said on Tuesday he would invoke the Defense Production Act if needed to ensure Americans are first in line for domestically produced coronavirus vaccines at a summit designed to give him and his team credit for speedy vaccine development. Trump made his remarks just before signing an executive order intended to ensure that priority access for COVID-19 vaccines procured by the U.S. government is given to the American people before assisting other nations. (Mason, 12/8)
The chief scientist of the Trump administrationās Operation Warp Speed was unable to explain President Donald Trumpās latest executive order Tuesday, which aims to prioritize shipment of the coronavirus vaccine to Americans over other countries. Moncef Slaoui, who Trump tapped in May to head up the administrationās efforts to hasten vaccine development, appeared puzzled when asked to clarify the presidentās order during an interview on ABCās āGood Morning America.ā āFrankly, I donāt know, and frankly, Iām staying out of this. I canāt comment,ā Slaoui said. āI literally donāt know.ā (Forgey, 12/8)
President Trump on Tuesday took a victory lap at a White House āSummitā meant to celebrate his administrationās remarkable sprint to develop a Covid-19 vaccine, using the event to claim credit for the effort and deride the experts who initially expressed skepticism at the governmentās hyper-aggressive timetable. (Facher, 12/8)
President Donald Trump on Tuesday gathered people at the White House to celebrate the "miracle" of a coronavirus vaccine. But the vaccine makers declined to attend. An introductory video tossed some of Trumpās own government scientists under the bus. And the man Trump tapped to help speed vaccine development spent the morning distancing himself from the executive order Trump signed at the event. (Niedzwiadek, 12/8)
Also ā
Former Food and Drug Administration Commissioner Scott Gottlieb, now a member of the Pfizer board of directors, said Tuesday thatĀ the pharmaceutical giantĀ offered the Trump administration the chance to buy additional doses of its coronavirus vaccine multiple times, but thatĀ officials turned down the offers. The comments from Gottlieb confirm a report in The New York Times, which on Monday revealed that additional doses of the Pfizer vaccine, beyond the 100 million already purchased, may not be available in the U.S. until June becauseĀ they were committed to other countries after theĀ Trump administration passed on them. (Sullivan, 12/8)
Given the Trump administrationās big promises on vaccines, the prospect of limited supply and long waits in the United States will lead to questions about where those doses are going. Here is what we know so far. (Rauhala, 12/8)
Even as President Trump claims credit for the rapid development of vaccines against COVID-19, it remains unclear whether he will take the vaccine and how hard heāll work to persuade skeptical followers to get immunized, particularly after he leaves office. Other former presidents ā Barack Obama, George W. Bush and Bill Clinton ā have publicly committed to taking the vaccine, which may be shipped out to medical centers and nursing homes as soon as this weekend. So have President-elect Joe Biden and Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Disease. (Levey and Megerian, 12/8)